
Diana Isaacs, PharmD, and Natalie Bellini, DNP, review OPTIMAL-DIABETES, SYNCHRONIZE-CVOT, and ATTAIN-OSA data from AHA 2026.
Catch up on key FDA approvals, major trial updates, and critical clinician insights from the last 3 months.
Endocrinology made some substantial progress over the last 3 months, between new treatments approved by the






